Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
PGD for Typhoid
Reference Number: NHSE(LR)/Typhoid v1.1 Page 1 of 6 Valid from: 1st April 2014 Review date: 1st January 2016 Expiry date: 31st March 2016
Patient Group Direction for the Administration of Typhoid Vaccine (Typherix®, or
TYPHIM Vi®)
This PGD must be read in conjunction with the core PGD (Reference:
NHSE(LR)/PGD/Core PGD for Immunisations), which details information that is common to all of the immunisation PGDs.
This PGD must only be used by registered healthcare professionals, working within NHS England (London Region), who have been named and authorised to practice
under it.
Version number: 1.1
Expiry date: 31st March 2016 The master copy for this PGD is held N:\2.0 Medical\Clinical Adviser Medicines\Patient Group Directions\Final Signed PGDs\Immunisation PGDs 2014 Change history Version number
Change details Date
1.0 First version December 2013 1.1 Revision of content March 2014
PGD for Typhoid
Reference Number: NHSE(LR)/Typhoid v1.1 Page 2 of 6 Valid from: 1st April 2014 Review date: 1st January 2016 Expiry date: 31st March 2016
PGD Development and Clinical Approval PGD Working Group This PGD was developed by a working group involving pharmacists from a number of Clinical Commissioning Groups across London, plus nurse representatives. Name and role Job title and organisation Jonathan Mason Pharmacist and Lead Author
Clinical Adviser (Medicines) NHS England (London Region)
Henrietta Hughes Doctor
Medical Director North Central and East London Area Team NHS England (London Region)
Eileen Bryant Nurse reviewer
Primary Care Nurse Adviser NHS England (London Region)
Nicola Pratelli Nurse Reviewer
Population Health Practitioner Manager Immunisation South NHS England (London Region)
Thara Raj Public Health Specialist
London Public Health Specialist (Immunisation) and Acting Public Health Consultant (Health in the Justice System) NHS England (London Region)
Nick Beavon Pharmacist Reviewer
Chief Pharmacist Wandsworth Clinical Commissioning Group
Raana Ali Pharmacist Reviewer
Senior Prescribing Adviser (Tower Hamlets) North and East London Commissioning Support Unit
Pauline Taylor Pharmacist Reviewer
Head of Medicines Management Haringey Clinical Commissioning Group
Helen Tsang Pharmacist Reviewer
Practice Link Pharmacist North West London Commissioning Support Unit
Dee Vadukul Pharmacist Reviewer
Senior Practice Pharmacist Richmond Clinical Commissioning Group
Seema Buckley Pharmacist Reviewer
Chief Pharmacist NHS Kingston Clinical Commissioning Group
References: • SmPC References for Typherix® and TYPHIM Vi®. Latest versions on eMC
(accessed March 2014): http://www.medicines.org.uk/emcmobile/medicine/2063/spc http://www.medicines.org.uk/emcmobile/medicine/6186/spc
• Green Book chapter on Typhoid vaccines (accessed March 2014): https://www.gov.uk/government/publications/typhoid-the-green-book-chapter-33
• NaTHNaC factsheet on Typhoid: http://www.nathnac.org/pro/factsheets/typhoid.htm
PGD for Typhoid
Reference Number: NHSE(LR)/Typhoid v1.1 Page 3 of 6 Valid from: 1st April 2014 Review date: 1st January 2016 Expiry date: 31st March 2016
PGD for Typhoid
Reference Number: NHSE(LR)/Typhoid v1.1 Page 4 of 6 Valid from: 1st April 2014 Review date: 1st January 2016 Expiry date: 31st March 2016
Patient Group Direction for the Administration of Typhoid Vaccine (Typherix® and TYPHIM Vi®)
Clinical condition or situation to which this PGD applies
Active immunisation against infection caused by the gram-negative bacterium Salmonella typhi.
Inclusion criteria Patient over 2 years of age: • Travelling to countries where typhoid is endemic (e.g.
South Asia, parts of South-East Asia, the Middle East, Central and South America, and Africa), especially if staying with or visiting the local population;
• Travelling to endemic areas (see above) with frequent and/or prolonged exposure to conditions where sanitation and food hygiene are likely to be poor;
• Laboratory personnel who may handle S. typhi in the course of their work.
Exclusion criteria As per the general exclusions stated in the Core PGD, plus: • Patient under 2 years of age; • Known hypersensitivity to components of the vaccine in
particular: o Formaldehyde - TYPHIM Vi®; o Phenol - Typherix®.
Special considerations/ additional information
• No protection is given against paratyphoid fever; • When given for travel purposes, the patient should be
given general travel advice, including good personal, food and water hygiene;
• Refer to the NATHNAC website and factsheet on typhoid for advice: http://www.nathnac.org/pro/factsheets/typhoid.htm
Details of the medicine Name, form and strength of medicine
Typhoid Polysaccharide vaccine in a pre-filled syringe (Typherix® and TYPHIM Vi®)
Dose 0.5ml
Frequency Primary course: single dose Booster: • Patients who remain at risk of typhoid fever should be
revaccinated using a single dose of Typhoid polysaccharide vaccine every 3 years;
• For information about boosting for or with Typhoid/ Hepatitis A combinations please refer to the PGD for the
PGD for Typhoid
Reference Number: NHSE(LR)/Typhoid v1.1 Page 5 of 6 Valid from: 1st April 2014 Review date: 1st January 2016 Expiry date: 31st March 2016
combined vaccines, and the SmPC for the specific vaccine.
Quantity 1 x 0.5ml
Adverse effects As detailed in the core PGD, plus common: itching. Refer to SmPC for complete list.
PGD for Typhoid
Reference Number: NHSE(LR)/Typhoid v1.1 Page 6 of 6 Valid from: 1st April 2014 Review date: 1st January 2016 Expiry date: 31st March 2016
Healthcare Professional’s Agreement to Practise and Practice/Pharmacy/Local Organisation Authorisation
PGDs DO NOT REMOVE INHERENT PROFESSIONAL OBLIGATIONS OR
ACCOUNTABILITY. IT IS THE RESPONSIBILITY OF EACH PROFESSIONAL TO PRACTISE ONLY WITHIN THE BOUNDS OF THEIR OWN COMPETENCE AND IN
ACCORDANCE WITH THEIR OWN CODE OF PROFESSIONAL CONDUCT. DECLARATION by healthcare professional: • I have read and understand this PGD; • I have been appropriately trained to understand the criteria listed, and the
techniques and record-keeping required to administer the vaccine in accordance with this PGD;
• The training has included both the theoretical and practical aspects of the techniques required to administer vaccines by the following routes (please tick as appropriate): Intramuscular injection □ Subcutaneous injection □
• I confirm that I have been assessed for my knowledge and clinical competency, and EITHER am experienced in administering vaccines in the past 12 months, OR I have been observed administering vaccines in practice;
• I confirm that I am competent to undertake administration of this vaccine; • I confirm that I will ensure that I remain up to date in all aspects of the
administration of this vaccine. Healthcare Professional’s Name:……………………………. Registration Number:………………………. Expiry Date: ………………………. Signature: …..………………….. Date: ………………………. Declaration by Authorising Manager*: Managers should only authorise staff who have received the required training and are competent to work to this PGD. Each authorised member of staff should be provided with an individual copy of the PGD, which they should also sign to declare themselves competent. A copy of the signed document should be kept by the individual staff member. The authorising manager should retain a copy of the signed individual authorisation page. I have read and understood the PGD and authorise the staff member named above to operate in accordance with this PGD. Authorising Manager’s Name:…………………………….. Signature: …..………………….. Date: ……………………….
*The term manager refers to the person taking responsibility for authorising healthcare professionals to operate under the terms of this PGD, and includes lead GPs, nurse managers, pharmacy managers etc.